Heater-Cooler Devices and Risk of Contamination during Cardiac Surgery.


Journal

The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 22 4 2021
medline: 1 2 2022
entrez: 21 4 2021
Statut: ppublish

Résumé

 Heater-cooler devices (HCD) have been implicated in a cardiosurgical contamination scenario causing prosthetic valve endocarditis.  We characterized contamination of new HCDs and assessed the risk of intraoperative microorganism transmission from the HCD to the operating field.  We initially acquired four new FlexTherm and then four new Maquet HCU40 HCDs and assessed occurrence and speed of microbial contamination (including mycobacteria) assessing swab and water samples from the device. In parallel, we collected repeated samples from different sites in the operating room either by swab sticks or by exposing different sample plates to room air. We also reviewed microbiological results from the hospital and compared them to cardiosurgical wound infections and endocarditis cases. Finally, we simulated cardiosurgical conditions and assessed the devices' ability to expel air to the operative field.  All new HCDs were clean before first use. Despite authority-mandated decontamination procedures, microbial growth (  HCDs cannot be expected to remain sterile despite extensive decontamination procedures. However, airborne transmission of microorganisms directly from the HCD to the operating field appears unlikely.

Sections du résumé

BACKGROUND BACKGROUND
 Heater-cooler devices (HCD) have been implicated in a cardiosurgical contamination scenario causing prosthetic valve endocarditis.
AIM OBJECTIVE
 We characterized contamination of new HCDs and assessed the risk of intraoperative microorganism transmission from the HCD to the operating field.
METHODS METHODS
 We initially acquired four new FlexTherm and then four new Maquet HCU40 HCDs and assessed occurrence and speed of microbial contamination (including mycobacteria) assessing swab and water samples from the device. In parallel, we collected repeated samples from different sites in the operating room either by swab sticks or by exposing different sample plates to room air. We also reviewed microbiological results from the hospital and compared them to cardiosurgical wound infections and endocarditis cases. Finally, we simulated cardiosurgical conditions and assessed the devices' ability to expel air to the operative field.
RESULTS RESULTS
 All new HCDs were clean before first use. Despite authority-mandated decontamination procedures, microbial growth (
CONCLUSION CONCLUSIONS
 HCDs cannot be expected to remain sterile despite extensive decontamination procedures. However, airborne transmission of microorganisms directly from the HCD to the operating field appears unlikely.

Identifiants

pubmed: 33882611
doi: 10.1055/s-0040-1721745
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

703-709

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Mirko Kaluza (M)

Department of Cardiothoracic Surgery, Jena University Hospital, Friedrich-Schiller University of Jena, Jena, Germany.
Life Systems Medizintechnik Service GmbH, Mönchengladbach, Germany.

Gloria Färber (G)

Department of Cardiothoracic Surgery, Jena University Hospital, Friedrich-Schiller University of Jena, Jena, Germany.

Benjamin May (B)

Department of Cardiothoracic Surgery, Jena University Hospital, Friedrich-Schiller University of Jena, Jena, Germany.

Ute Dobermann (U)

Center for Infectious Diseases and Infection Control, Jena University Hospital, Friedrich-Schiller University of Jena, Jena, Germany.

Mathias W Pletz (MW)

Center for Infectious Diseases and Infection Control, Jena University Hospital, Friedrich-Schiller University of Jena, Jena, Germany.

Birgit Edel (B)

Institute of Medical Microbiology, Jena University Hospital, Friedrich-Schiller University of Jena, Jena, Germany.

Bettina Löffler (B)

Institute of Medical Microbiology, Jena University Hospital, Friedrich-Schiller University of Jena, Jena, Germany.

Torsten Doenst (T)

Department of Cardiothoracic Surgery, Jena University Hospital, Friedrich-Schiller University of Jena, Jena, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH